Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Las Vegas, NV
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Ocean City, NJ
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Ocean City, NJ
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Winston-Salem, NC
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
319, Novartis Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
North Myrtle Beach, SC
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
North Myrtle Beach, SC
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Greenville, TN
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Greenville, TN
Click here to add this to my saved trials
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Sugar Land, TX
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Springs, CA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southern California Desert Retina Consultants, MC
mi
from
Palm Springs, CA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
mi
from
Westlake Village, CA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Southwest Florida
mi
from
Fort Myers, FL
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Central Florida Retina Institute
mi
from
Lakeland, FL
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Hawaii, Inc.
mi
from
Honolulu, HI
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Hawaii, Inc.
mi
from
Honolulu, HI
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
American Eye Institute
mi
from
New Albany, IN
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
American Eye Institute
mi
from
New Albany, IN
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
mi
from
Paducah, KY
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eyesight Ophthalmic Services, PA
mi
from
Portsmouth, NH
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Eye Care for the Adirondacks
mi
from
Plattsburgh, NY
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eye Care for the Adirondacks
mi
from
Plattsburgh, NY
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
mi
from
Portland, OR
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Family Eye Group
mi
from
Lancaster, PA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Family Eye Group
mi
from
Lancaster, PA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates, PC
mi
from
Kingsport, TN
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates, PC
mi
from
Kingsport, TN
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Texas Retina Associates
mi
from
Lubbock, TX
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
A Phase II Evaluation of Topical Non-steroidal Anti-inflammatories in Eyes With Non Central Involved Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Texas Retina Associates
mi
from
Lubbock, TX
Click here to add this to my saved trials
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Status: Enrolling
Updated:  12/31/1969
127 S. San Vicente Blvd, Suite A9303
mi
from
Los Angeles, CA
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Status: Enrolling
Updated: 12/31/1969
127 S. San Vicente Blvd, Suite A9303
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jackson, MS
Gadobutrol Enhanced MRA of the Supra-aortic Vessels
Multicenter, Open-label Study to Evaluate the Safety and Efficacy (by Blinded Reading) of Contrast-Enhanced Magnetic Resonance Angiography (MRA) After a Single Intravenous Injection of 0.1 mmol/kg Gadobutrol in Subjects With Known or Suspected Vascular Disease of the Supra-aortic Vessels
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials